[Clinical tests of combined Rauwolfia, bromocholine bromide & papaverine hydrochloride in the treatment of arterial hypertension].
D000470:Alkaloids; D000959:Antihypertensive Agents; D001965:Bromides / Q000627:therapeutic use*; D002794:Choline / Q000031:analogs & derivatives; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D006993:Hypnotics and Sedatives; D010208:Papaverine / Q000627:therapeutic use*; D011926:Rauwolfia; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*
D000470:Alkaloids; D000959:Antihypertensive Agents; D001965:Bromides; D006993:Hypnotics and Sedatives; D046948:Secologanin Tryptamine Alkaloids; D010208:Papaverine; D002794:Choline
BROMIDES/therapeutic use; CHOLINE/related compounds; HYPERTENSION/therapy; PAPAVERINE/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use
Ensayo clínico de la Rauwolfia, bromuro de bromocolina, y clorhidrato de papaverina combinados, en el tratamiento de la hipertensión arterial.